Li S - Search Results

1

Identification of Metabolites of Eupatorin in Vivo and in Vitro Based on UHPLC-Q-TOF-MS/MS.

Li L, Chen Y, Feng X, Yin J, Li S, Sun Y, Zhang L. Li L, et al. Among authors: li s. Molecules. 2019 Jul 23;24(14):2658. doi: 10.3390/molecules24142658. Molecules. 2019. PMID: 31340434 Free PMC article.

2

A comprehensive study of eriocitrin metabolism in vivo and in vitro based on an efficient UHPLC-Q-TOF-MS/MS strategy.

Li L, Feng X, Chen Y, Li S, Sun Y, Zhang L. Li L, et al. Among authors: li s. RSC Adv. 2019 Aug 12;9(43):24963-24980. doi: 10.1039/c9ra03037a. eCollection 2019 Aug 8. RSC Adv. 2019. PMID: 35528661 Free PMC article.

3

A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.

Li S, Hao L, Hu X, Li L. Li S, et al. Among authors: li l. Infect Agent Cancer. 2023 Jul 1;18(1):41. doi: 10.1186/s13027-023-00520-z. Infect Agent Cancer. 2023. PMID: 37393234 Free PMC article.

4

Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.

Peng Q, Li S, Shi X, Guo Y, Hao L, Zhang Z, Ji J, Zhao Y, Li C, Xue Y, Liu Y. Peng Q, et al. Among authors: li s, li c. Phytother Res. 2023 May;37(5):1740-1753. doi: 10.1002/ptr.7695. Epub 2022 Dec 28. Phytother Res. 2023. PMID: 36576358

5

The current status and future of PD-L1 in liver cancer.

Hao L, Li S, Deng J, Li N, Yu F, Jiang Z, Zhang J, Shi X, Hu X. Hao L, et al. Among authors: li s, li n. Front Immunol. 2023 Dec 12;14:1323581. doi: 10.3389/fimmu.2023.1323581. eCollection 2023. Front Immunol. 2023. PMID: 38155974 Free PMC article. Review.

6

Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer.

Hao L, Li S, Peng Q, Guo Y, Ji J, Zhang Z, Xue Y, Liu Y, Shi X. Hao L, et al. Among authors: li s. Oncol Lett. 2021 Sep;22(3):653. doi: 10.3892/ol.2021.12914. Epub 2021 Jul 9. Oncol Lett. 2021. PMID: 34386075 Free PMC article.

7

Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1.

Hao L, Li S, Chen G, Nie A, Zeng L, Xiao Z, Hu X. Hao L, et al. Among authors: li s. Chem Biol Drug Des. 2024 Jun;103(6):e14567. doi: 10.1111/cbdd.14567. Chem Biol Drug Des. 2024. PMID: 38858165

8

Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.

Li S, Ji J, Zhang Z, Peng Q, Hao L, Guo Y, Zhou W, Cui Q, Shi X. Li S, et al. Mol Cell Biochem. 2020 Dec;475(1-2):79-91. doi: 10.1007/s11010-020-03861-0. Epub 2020 Aug 6. Mol Cell Biochem. 2020. PMID: 32761300

9

Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review).

Li S, Hao L, Li N, Hu X, Yan H, Dai E, Shi X. Li S, et al. Among authors: li n. Int J Oncol. 2024 Sep;65(3):88. doi: 10.3892/ijo.2024.5676. Epub 2024 Aug 2. Int J Oncol. 2024. PMID: 39092548 Free PMC article. Review.

10

Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress.

Shi X, Wang L, Li X, Bai J, Li J, Li S, Wang Z, Zhou M. Shi X, et al. Among authors: li s, li j, li x. Oncotarget. 2017 Jul 11;8(28):45981-45993. doi: 10.18632/oncotarget.17520. Oncotarget. 2017. PMID: 28526807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,782 results

Search Page

Filters